Insights on Discovery
-
Rapid Production Of Assay Ready Cells For GPCR Drug Discovery
7/29/2025
Accelerate drug discovery by leveraging transiently transfected assay-ready cells. This method improves assay sensitivity and reduces variability for GPCRs.
-
A Novel Cell-Based Assay For Ubiquitin Drug Discovery
7/29/2025
Learn about a novel cell-based assay that can advance ubiquitin ligase drug discovery. This high-throughput method simplifies assay development, saving time and resources.
-
High-Throughput Screening Of Ion Channel Variants Using Automated Patch Clamp Recordings In Assay Ready Cells
7/29/2025
High-throughput screening of KCNQ2 ion channel variants provides insights into epilepsy and treatment responses. This validated method supports rapid characterization for precision medicine.
-
Risk Assessment Services Align With FDA Guidance For Gene-Edited Human Gene Therapy Products
7/29/2025
Navigate the FDA's gene therapy guidelines with advanced risk assessment strategies. Optimize gene editing and ensure regulatory alignment for safer, more effective therapies.
-
Mammalian Display Method For The Development Of Enhanced Affinity TCR-Based Biologics
7/29/2025
Discover how mammalian display enhances T cell receptor-based cancer therapies. This method improves antigen affinity and reduces immunogenicity for more effective treatments.
-
Improved Cell Viability For Multi-Day Cell-Based Assays
7/24/2025
Ensure consistent cell health and assay reliability with controlled temperature and gas conditions. Discover how microplate readers with gas mixers enhance cell viability in live cell-based assays.
-
Viral Gene Therapy: Reducing Costs To Improve Patient Access
7/23/2025
Gene therapy is revolutionizing medicine with its potential to cure genetic disorders. As approvals rise, so do concerns about accessibility, with million-dollar price tags limiting patient access.
-
Accelerating Gene Therapy Development For NEDAMSS
7/15/2025
Discover how one family's race against time led to the creation of a groundbreaking gene therapy for their daughter, just 14 months after her ultra-rare disease diagnosis.
-
Optimized Urine Liquid Biopsy Workflow
7/14/2025
Urine-derived cell-free DNA is revolutionizing liquid biopsy research to offer a non-invasive, accessible tool for early disease detection, monitoring, and comprehensive diagnostics across oncology.
-
Powering More Efficient Clinical Development With AI And ML
7/7/2025
Explore how AI and ML are revolutionizing clinical trials by automating data processes to accelerate research and transform data into actionable outcomes for patient care.